This site is intended for Healthcare Professionals only.

Fluoxetine 10mg out of stock until mid-August

Date:

Share post:

Fluoxetine 10mg tablets will remain out of stock until August 13, the Department of Health and Social Care (DH) said in an update to community pharmacy teams.

A Serious Shortage Protocols (SSP05) issued for Fluoxetine 10mg tablets was expected to expire on May 17. The SSP05 provides that 1 x Fluoxetine 10mg capsule may be supplied for every prescribed Fluoxetine 10mg tablet as follows:

For prescriptions (NHS or private) requesting: Supply permitted under SSP05: Current expiry date
Fluoxetine 10mg tablets 1 x Fluoxetine 10mg capsule This SSP has been varied – the revised end date for SSP05 is now Friday 13th August 2021

 

Pharmacy contractors will receive reimbursement for the medicine supplied in accordance with the SSP.

The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor:

  • One Single Activity fee (currently £1.27)
  • One SSP fee (£5.35)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

NHS virtual wards set to slash waiting times, prevent 178k admissions in next 2 years

Under the new NHS virtual wards scheme, hospitals to be incentivised for prompt care, with 12-hour A&E target In...

Pharmacist Support: Trainee pharmacists get set to ACTNow for mental health awareness ahead of GPhC assessment

Pharmacist Support's annual mental health awareness campaign offers vital support ahead of GPhC assessment and registration transition Trainee pharmacists...

Two pharmacists sentenced to two years for illegally supplying Class C Drugs

They unlawfully supplied over 55 million doses of Class C drugs diazepam, zolpidem, and zopiclone Southwark Crown Court on...

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce The...